PTU - Polskie Towarzystwo Urologiczne
home page
current numbers
archival numbers
list of articles:
list przewodni/covering letter
editor
Scientific Committee
publisher
subscription
advertising
important links

The significance of immunohistochemical evaluation of prolifcratic activity in the case of prostate cancer
Article published in Urologia Polska 2001/54/2.

authors

Zdzisław Skok, Mieczysław Gajda
Katedra i Zakład Patomorfologii Klinicznej AM w Bydgoszczy Kierownik: prof. zw. dr hab. med. Jan Domaniewski

keywords

prostate, cancer, proliferation markers, PCNA, Ki-67, proliferation index

references

  1. [1] Zatoński W.. Tyczyński J.: Now roku. Biuletyn Centrum Onkolo< Curie, Centrum Onkologii. Wai
  2. [2] Weingartner K.. Riedmiller H.: [B] 1998,38, 186-193.
  3. [3]Wirth M. P., Froschermaier,S.E., radikalen Prostetektomie - Wann? Urologe [B]. 1998. 38. S 65-S 69.
  4. [4] Fainnan VI P.: DNA polymerase delta/PCNA: actions anil interactions. .1. Cell Sci„ 1990, 95, 1-4.
  5. [5] Domagała W.: Classical and new prognostic antl predictive factors in breast carcinoma. Nowotwory. 1996. 46, 669-690.
  6. [6] Hall P. A.. Levison D. A.: Review: assessment of cell proliferation in histological material. J. Clin. Patliol.1990, 43. 184-192.
  7. [7] Keim D. R.. Ilanash S. M.: Proliferating cell nuclear antigen: a new marker of proliferation in cancer. Leuk. Lymphoma. 1992, 6, 459-65.
  8. [8] Waseem N.H., Lane D. P.: Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form J. Cell. Sci.
  9. [9] (icrdes J.. Schwab U.. Lemke H.. Stein H.: Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer. 1983,31, 13-20.
  10. [10] Cattorelti G., Becker N. M.. Key O: Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and M1B-3) delect proliferating cells in microwaveprocessed formalin-fixed paraffin sections. .1. Pathol. 1992, 168.357-363.
  11. [11] Gleason D. F.: Histological grading and clinical staging of prostatic carcinoma. Urologie Pathology: the prostate. Lea and Fe-higer. Philadelphia 1977.
  12. [12] Linden N. M., Torres F. X.. Kubus J.. Zabro R J.: Clinical Application of Morphologic and lmmunocylochemical Assessment of Cell Proliferation, Am. J. Clin. Pathol. 1992, 97, S4-SI3.
  13. [13] Maeda K., Chung Y.. Omoda N., Kato Y., Nina Arimoto Yamcda N., Hondo Y., Sowa M: Proliferating cell nuclear antigen labeWig index o/ preoperative biopsy specimens in gastric carcith with special reference to prognosis. Cancer. 1994. 73.528-53
  14. [14] Kawai T., Suzuki M., Kono S.. Shiromiya N.. Rokutanda Takagi K.. Ogata T., Tamai S.: Proliferating Cell Nuclear A gen and Ki-67 in lung carcinoma. Cancer 1994. 74. 2468-7
  15. [15] GafTney E. F., O\\\'Sullivan S. N.. O\\\'Brain A.: A major solid in ferentiuted carcinoma pattern correlates with tumor progres. in locally advanced prostatic carcinoma. HiSlOpathology. I1 21.249-255.
  16. [16] Helpap Li.: Prognosefaktoren des Prostatakaninoms- Der Pa loge. 1998. 19.42-52.
  17. [17] Slattin I\\\'., DamberJ. F... Karlbcrg L.. Bergh A.: Cell prolifen, assessed by Ki-67 Immunoreucliviry on formalin fixed tissiii a predictive factor for survival in prostate Cancer. J. Urol. 157,219-222.
  18. [18] Taylor C.R.. Shi S. R., Chaiwun B.. Young L.. Imam S. Cole R.J.: Strategies for improving the inimiinoliistochem staining of various intranuclear prognostic markers in jot lin-parulftn sections: androgen receptor, estrogen rece/ progesterone receptor, p.f.1 protein, proliferating cell nuc antigen, and Ki-67 antigen revealed retrieval techniques. H Pathol, 1994,25.263-270.
  19. [19] Ncmoto R.. Kawamura 11.. Miyakawa I., Uchida K.. Haltor Koiso K„ Harada .VI.: linmunohistocheinical detection of pre rating cell nuclear antigen (PCNA)/cyclin in human pro: adenocarcinoma. J. Urol. 1993.153. 165-169.
  20. [20] Galke VI.R W., Nisser-De Jong E.. Ten Kaltc F, J. W., Schr F. II., Kwast T. II.: Monoclonal antibody Ki 67 defined grt fraction in benign prostatic hyperplasia and prostatic. Cane Urol.. 1989. 142, 1342-1346.
  21. [21] Striepeckc E.. Ilandt S.. Efferl R, Gricfingholt H.. Bockint TV-bildanalytische Quanti/tierimg der Proliferationsfraktion, in benignen mid malignen Verdnderungen der Prostata: Vergl von Ki-67 und PCNA. Vcrh. Dtsch. Ges. Path., 1994, 78, 40

correspondence

Zdzisław Skok
ul. Osiedlowa 3/6 85-799 Bydgoszcz